Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Share-based Compensation (2016 - 2026)

Iradimed has reported Share-based Compensation over the past 14 years, most recently at $684000.0 for Q1 2026.

  • Quarterly Share-based Compensation fell 17.19% to $684000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Mar 2026, up 2.04% year-over-year, with the annual reading at $2.9 million for FY2025, 15.65% up from the prior year.
  • Share-based Compensation was $684000.0 for Q1 2026 at Iradimed, down from $696236.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $826000.0 in Q1 2025 and troughed at $121003.0 in Q2 2022.
  • The 5-year median for Share-based Compensation is $609096.0 (2024), against an average of $571055.9.
  • Year-over-year, Share-based Compensation plummeted 66.2% in 2022 and then soared 369.79% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $426555.0 in 2022, then grew by 29.19% to $551064.0 in 2023, then grew by 19.1% to $656299.0 in 2024, then rose by 6.09% to $696236.0 in 2025, then fell by 1.76% to $684000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Share-based Compensation are $684000.0 (Q1 2026), $696236.0 (Q4 2025), and $666083.0 (Q3 2025).